Dr. McMahan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 450
Houston, TX 77030Phone+1 713-486-3100Fax+1 713-500-0580
Education & Training
- Johns Hopkins UniversityFellowship, Rheumatology, 2009 - 2012
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2006 - 2009
- McGovern Medical School at UTHealthClass of 2006
Certifications & Licensure
- TX State Medical License 2008 - 2025
- MD State Medical License 2012 - 2023
- NC State Medical License 2020 - 2022
- PA State Medical License 2020 - 2022
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 2 citationsEvaluating the Associations Among Dysautonomia, Gastrointestinal Transit, and Clinical Phenotype in Patients With Systemic Sclerosis.Maria Paula Alvarez-Hernandez, Brittany Adler, Jamie Perin, Michael Hughes, Zsuzsanna H McMahan
Arthritis Care & Research. 2024-12-01 - Anti-mitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility.Zsuzsanna H McMahan, Livia Casciola-Rosen, Timothy Kaniecki, Laura Gutierrez-Alamillo, Su Hong Ming
Medrxiv. 2024-11-30 - 1 citationsJoint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysfunction, and Autoimmune Markers: Clinical Associations and Response to Intravenous Immunoglobulin Ther...Pankaj J Pasricha, Megan McKnight, Luisa Villatoro, Guillermo Barahona, Jeffrey Brinker
The American Journal of Gastroenterology. 2024-11-01
Journal Articles
- Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal DysmotilityRobyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research
Authored Content
- Pyridostigmine for the Treatment of Gastrointestinal Symptoms in Systemic SclerosisJanuary 2018
Press Mentions
- Clinical Science Sessions Full of New GuidelinesOctober 27th, 2022
- Scleroderma & the Gut: New Frontiers in Diagnosis & Tips on ManagementMay 12th, 2022
- What Is Scleroderma? These Are the Signs You Could Have ItDecember 24th, 2019
- Join now to see all
Other Languages
- Spanish, Hungarian
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/zsuzsanna-mcmahan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: